Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00551694 · ClinicalTrials.gov registry record · Phase 1
A Second Study to Determine the Effect of GSK256073A on HVTs
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 4
- Enrollment target
NCT00551694 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 4 participants.
The verdict
NCT00551694, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the effects of single and repeat doses of GSK256073 with placebo in HVT subjects that have been administrated GSK256073 in the HMA107787 study
Interventions
- DRUG GSK256073A tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2007-10 |
| Est. Completion | 2007-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00551694
The ClinicalTrials.gov registry entry for NCT00551694 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GSK256073A tablets is the first listed.
NCT00551694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00551694 about?
NCT00551694 is a clinical study titled "A Second Study to Determine the Effect of GSK256073A on HVTs". The purpose of this study is to compare the effects of single and repeat doses of GSK256073 with placebo in HVT subjects that have been administrated GSK256073 in the HMA107787 study
What is the current status of trial NCT00551694?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 4 participants. The study started on 2007-10. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00551694?
The interventions under investigation include: GSK256073A tablets (DRUG).
Who is sponsoring clinical trial NCT00551694?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.